Keyphrases
Humoral Response
100%
Maintenance Dialysis
100%
Anti-S
100%
SARS-CoV-2 mRNA Vaccine
100%
BNT162b2
100%
Antibody Response
75%
2-dose
50%
Low Response
50%
High Risk
25%
Risk Factors
25%
Multivariable
25%
Academic Center
25%
Clinical High Risk
25%
End-stage Renal Disease
25%
Patient Demographics
25%
Single Center
25%
Preventive Measures
25%
Lack of Response
25%
Associated Morbidity
25%
Protective Immunity
25%
Dialysis
25%
Peritoneal Dialysis
25%
Vaccine Response
25%
Dialysis Patients
25%
COVID-19 Mortality
25%
Vaccine Strategy
25%
Dialysis Facility
25%
Second Dose
25%
Index Score
25%
No Response
25%
Non-response
25%
Comorbidity Index
25%
Black Race
25%
Disease Comorbidity
25%
Vaccine Dose
25%
In-center Hemodialysis
25%
Hepatitis B Vaccine
25%
Severe COVID-19
25%
Outpatient Dialysis
25%
Anti-SARS-CoV-2 Spike Antibody
25%
Medicine and Dentistry
Antibody Response
100%
Humoral Immunity
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
mRNA Vaccine
100%
End Stage Renal Disease
33%
Cohort Analysis
33%
Study Participant
33%
Outpatient
33%
Patient Population
33%
Hemodialysis
33%
Peritoneal Dialysis
33%
COVID-19
33%
Factor Analysis
33%
Hepatitis B Vaccination
33%
Comorbidity
33%